Recerca > Malalties cròniques, Cirurgia i Cures en Salut

Grup de Recerca en Malalties Digestives

Nombre de publicacions
92
Cercador de publicacions

  • Revuelto Artigas T; Betriu Bars À; Zaragoza Velasco N; Gómez Arbones X; Vidal Ballester T; Piñol Felis C; Reñé Espinet JM

    Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis c virus

    GASTROENTEROLOGIA Y HEPATOLOGIA 42 362-371. .

    [doi:10.1016/j.gastrohep.2019.02.002]

  • Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J

    beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

    Lancet 393 1597-1608. .

    [doi:10.1016/S0140-6736(18)31875-0]

  • Ballester-Clau, R; Torres Vicente, G; Volta-Pardo, T; Lopez-Barroso, L; Cucala-Ramos, M; Reñé-Espinet JM; Planella de Rubinat, Montse

    Clinical experience with ferric carboxymaltose in the management of anemia in acute gastrointestinal bleeding

    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY 31 116-122. .

    [doi:10.1097/MEG.0000000000001282]

  • Ardevol, A; Ibañez-Sanz G; Profitos, J; Aracil, C; Castellvi, JM; Alvarado, E; Cachero, A; Horta, D; Miñana J; Gomez-Pastrana, B; Pavel, O; Dueñas E; Casas, M; Planella, M; Castellote, J; Villanueva, C

    Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies

    Hepatology 67 1458-1471. .

    [doi:10.1002/hep.29370]

  • Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M

    Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers

    MEDICINA CLINICA 149 61-71. .

    [doi:10.1016/j.medcli.2016.12.048]

  • Garcia-Iglesias, P; Botargues, JM; Feu Caballé F; Villanueva Sánchez C; Calvet Calvo X; Brullet Benedi E; Cánovas Moreno G; Fort Martorell E; Gallach Montero M; Gené Tous E; Hidalgo Rosas JM; Lago Macía A; Nieto Rodríguez A; Papo Berger M; Planella de Rubinat M; Saló Rich J; Campo Fernández de Los Ríos R

    Management of non variceal upper gastrointestinal bleeding: position statement of the Catalan Society of Gastroenterology

    GASTROENTEROLOGIA Y HEPATOLOGIA 40 363-374. .

    [doi:10.1016/j.gastrohep.2016.11.009]

  • Villanueva, C; Graupera, I; Aracil, C; Alvarado, E; Minana, J; Puente, A; Hernandez-Gea, V; Ardevol, A; Pavel, O; Colomo, A; Concepcion, M; Poca, M; Torras, X; Rene, JM; Guarner, C

    A Randomized Trial to Assess Whether Portal Pressure Guided Therapy to Prevent Variceal Rebleeding Improves Survival in Cirrhosis

    Hepatology 65 1693-1707. .

    [doi:10.1002/hep.29056]

  • Villanueva, C.; Albillos, A.; Genesca, J.; Garcia-Pagan, J. C.; Calleja, J. L.; Aracil, C.; Banares, R.; Morillas, R.; Poca, M.; Penas, B.; Augustin, S.; Abraldes, J. G.; Alvarado, E.; Torres, F.; Bosch, J.

    Preventing decompensation of cirrhosis with clinically significant portal hypertension and without high-risk varices: a new indication for non-selective beta-blockers (NSBB)

    JOURNAL OF HEPATOLOGY 66 97-98. .

    [doi:10.1016/S0168-8278(17)30455-5]

  • Fernandez, J; Aracil, C; Sola, E; Soriano, G; Cinta Cardona, M.; Coll, S; Genesca, J; Hombrados, M; Morillas, R; Martin-Llahi, M; Pardo, A; Sanchez, J; Vargas, V; Xiol, X; Ginès, P.

    Evaluation and treatment of the critically ill cirrhotic patient

    GASTROENTEROLOGIA Y HEPATOLOGIA 39 607-626. .

    [doi:10.1016/j.gastrohep.2015.09.019]

  • Acero Fernández D; Morillas Cunill R; Ferri Iglesias MJ; Torras Collell X; Vergara Gómez M; Zaragoza Velasco N; López Nuñez C; Forné Bardera M; Delgado Gómez M; Barenys Lacha M; Torres Salinas M; Villar Fernández M; Durández Lázaro R; Mariño Mendez Z

    Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection

    GASTROENTEROLOGIA Y HEPATOLOGIA 39 377-384. .

    [doi:10.1016/j.gastrohep.2015.10.005]

  • Abraldes JG; Villanueva C; Aracil C; Turnes J; Hernandez-Guerra M; Genesca J; Rodriguez M; Castellote J; García-Pagán JC; Torres F; Calleja JL; Albillos A; Bosch J

    Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

    Gastroenterology 150 1160-1160. .

    [doi:10.1053/j.gastro.2016.01.004]

  • Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J

    Development of hyperdynamic circulation and response to -blockers in compensated cirrhosis with portal hypertension

    Hepatology 63 197-206. .

    [doi:10.1002/hep.28264]